David Surrey Dane
The National Blood Authority in England
Transfusion-associated graft-versus-host disease: new insights and a route towards therapy?
A prospective study of the risk of transfusion-acquired viral infections
Changes in red-cell transfusion practice in a tertiary care hospital during the 1990s - a 7-year study
A survey of blood utilization in children and adolescents in a German universitty hospital
Blood transfusion and total joint replacement surgery: T helper 2 (TH2) cytokine secretion and clinical outcome
Complement activation during plasma production depends on the apheresis technique
Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease
Evaluation and eligibility of HLA-identical sibling donors for stem cell/bone marrow donation
Serious adverse events after HPA-incompatible platelet transfusions in an alloimmunized patient with leukaemia
New reference reagent for the quality assurance of anti-D antibody detection
Heterogeneity of the blood group A x allele: genetic recombination of common alleles can result in the Ax phenotype
Mystery plasma lectin was a contaminant
Guide to the Preparation, Use and Quality Assurance of Blood Components.
Polymorphisms of platelet glycoproteins and their clinical aspects
MOLECULAR AND CLINICAL ASPECTS OF GRANULOCYTE ANTIGENS
MOLECULAR AND FUNCTIONAL ASPECTS OF RED CELL ANTIGENS
PLASMA THROMBOPOIETIN (TPO) LEVELS: REGULATION AND CLINICAL RELEVANCE
CLINICAL EVALUATION OF RECOMBINANT HUMAN THROMBOPOIETIN IN PATIENTS WITH SOFT-TISSUE SARCOMAS ON DOSE-INTENSIVE CHEMOTHERAPY.
MEGAKARYOCYTE DEVELOPMENT FROM BONE MARROW, CORD BLOOD OR PERIPHERAL BLOOD DERIVED PROGENITOR CELLS.
DIAGNOSTIC APPROACH TO THROMBOCYTOPENIAS OFTEN MISDIAGNOSED AS AUTOIMMUNE THROMBO-CYTOPENIC PURPURA (AITP)
FROM NATURAL TO DISEASE-RELATED AUTOANTIBODIES AGAINST PLATELET GLYCOPROTEIN IIB/IIIA
European Experience of the antenatal management of NAIT
SCREENING FOR FETO-MATERNAL ALLOIMMUNE THROMBOCYTOPENIA (FMAIT) - ANTENATAL OR POSTNATAL?
PROPOSAL FOR A EUROPEAN ANTENATAL SCREENING STUDY OF FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA (FMAIT) DUE TO ANTI-HPA-1a.
Platelet transfusion refractoriness beyond the immunological factors.
MHC class I molecules and their ligands: structural studies on peptide presentation and recognition by lymphocyte receptors
MOLECULES ASSOCIATED WITH MHC-I AND II: THEIR ROLE IN AUTOANTIGEN PRESENTATION BY EPITHELIAL CELLS
LEUCOCYTE INHIBITORY RECEPTORS SPECIFIC FOR HLA CLASS I MOLECULES
Profiles of peptides eluted from Class II HLA molecules: impact in the understanding of autoimmunity.
MOLECULAR HLA TYPING: NEWS AND FUTURE.
FcRn AND ITS ROLE IN IMMUNOGLOBULIN G PLACENTAL TRANSPORT AND CATABOLISM.
IgG RECEPTOR POLYMORPHISMS AS RISK FACTORS FOR INFECTIOUS AND AUTOIMMUNE DISEASE
THE PLATELET FcγRIIa RECEPTOR IN HEPARIN-INDUCED THROMBOCYTOPENIA: DON'T TRUST THE LAB-TUBE
CLINICAL RELEVANCE OF THE FcγRIIIA POLYMORPHISM.
HUMAN ANTIBODY VARIABLE DOMAINS, WHERE ARE WE GOING?
IN VITRO MEGAKARYOPOIESIS: STUDIES USING VARIOUS COMBINATIONS OF THROMBOPOIETIN (Tpo), IL3, IL11 AND STEM CELL FACTOR (SCF)
MONITORING OF THROMBOPOIESIS BY THROMBOPOIETIN AND RETICULATED PLATELETS AFTER PLATELETPHERESIS
Plasma thrombopoietin levels in hematological disorders, in liver and in kidney failure.
SERUM THROMBOPOIETIN LEVELS IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA.
THE DIAGNOSTIC VALUE OF THROMBOPOIETIN LEVEL MEASUREMENTS IN THROMBOCYTOPENIA.
THE "HARRINGTON MOUSE": AN ANIMAL MODEL FOR HUMAN IMMUNE THROMBOCYTOPENIA.
HEAVY-CHAIN AND LIGHT-CHAIN PHENOTYPE COMPOSITIONS OF GLYCOPROTEIN-SPECIFIC IgG ANTIBODIES IN CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
CHARACTERIZATION OF PLATELET-REACTIVE T CELL LINES FROM PATIENTS WITH AUTOIMMUNE THROMBOCYTOPENIC PURPURA (AITP).
LYMPHOCYTES FROM PATIENTS WITH AUTOIMMUNE THROMBOCYTOPENIC PURPURA HAVE ALTERED TYROSINE PHOSPHORYLATION
GENOTYPING OF HUMAN PLATELET ANTIGENS (HPA) -1, -3 AND -4, USING F-SSCP TECHNIQUE AND AUTOMATIC DNA ANALYSER
MULTICENTRE INTERNATIONAL TRIAL OF AN ELISA KIT FOR SIMULTANEOUS PLATELET HPA-1 PHENOTYPING AND ANTI-HPA1a ANTIBODY TESTING.
RAPID PLASMA BASED HPA-1a TYPING WITH RECOMBINANT MONOCLONAL ANTIBODIES.
A CONVENIENT DNA TYPING METHOD FOR DETECTION OF PREGNANT HPA-1a NEGATIVE WOMEN: APPLICATION TO NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT) MANAGEMENT.
SUBSEQUENT PREGNANCIES IN HPA-1A NEGATIVE WOMEN PREVIOUSLY IDENTIFIED BY ANTENATAL SCREENING
INTRAVENOUS GAMMAGLOBULINS (IVIg) FROM MULTIPAROUS SERA BIND SIGNIFICANTLY MORE ANTI-HLA COMPARED WITH COMMERCIAL IVIg.
ANTI-GOV ALLOANTIBODIES DETECTED BY MAIPA ASSAY
THE RECIPIENT IMMUNE MECHANISMS WHICH DETERMINE IgG RESPONSIVENESS AGAINST ALLOGENIC PLATELETS.
ELEVATED EXPRESSION OF A1 AND B ANTIGENS ON PLATELETS
IDENTIFICATION AND ANALYSIS OF TRANSFUSED PLATELETS USING WHOLE BLOOD TWO-COLOUR FLOW CYTOMETRY.
A PLATELET ANTIBODY SCREENING AND CROSSMATCHING PROTOCOL FACILITATES SUCCESSFUL PLATELET TRANSFUSION TO PATIENTS WITH HAEMATOLOGICAL MALIGNANCY
PEDIATRIC PLATELET CONCENTRATES FROM SINGLE BUFFY COATS IN ADDITIVE SOLUTION
QUALITY ASSESSEMENT OF PLATELET CONCENTRATES FOLLOWING PRE-STORAGE LEUKODEPLETION BY A NEW IN-LINE FILTER.
HIGH CONCENTRATION LEUCOCYTE-REDUCED PLATELETS FOR IN UTERO TRANSFUSIONS USING COBE SPECTRA LRS
NEW ALLELES OF THE PLATELET GLYCOPROTEIN Ibα GENE
GLYCOPROTEIN V PLAYS AN IMPORTANT ROLE IN AITP.
CD36 DEFICIENCY IS FREQUENT AND CAN CAUSE PLATELET IMMUNIZATION IN AFRICANS
One amino acid deletion of the PIA2 allelic form of GPIIIa leads to the formation of the new platelet alloantigen, Oe(a)
THE Br(a/b) ALLELES AND A C807 T POLYMORPHISM DEFINE THREE ALLELES OF GLYCOPROTEIN Ia
GENETIC ASSOCIATION BETWEEN NUCLEOTIDE 807C/T AND AMINO ACID 505 Glu/Lys (HPA-5) DIMORPHISMS OF THE PLATELET GLYCOPROTEIN Ia (α2 INTEGRIN) GENE.
THE LARGEST ISOFORM OF PLATELET MEMBRANE GLYCOPROTEIN Ibα IS ABSENT IN A SOUTH-AMERINDIAN (MAPUCHE) POPULATION.
Ligated Products of Site Directed Mutagenesis Provides a Novel Approach to the Provision of Human Platelet Antigen (HPA) DNA Control Material, for Polymerase Chain Reaction with Sequence Specific Primers (PCR-SSP).
Establishment of B-lymphoblastoid cell panel for DNA typing of human platelet and granulocyte antigens
A HUMAN MONOCLONAL ANTI-HLA-A2 ANTIBODY FROM A V GENE PHAGE DISPLAY LIBRARY.
RECOMBINANT IgG LACKING FcγRI BINDING AND COMPLEMENT/CHEMILUMINESCENCE ACTIVATION.
BASEPAIR SUBSTITUTIONS IN THE HVR-1 REGION OF THE HUMAN MITOCHONDRIAL GENOME IN UNRELATED GERMAN PLATELETAPHERESIS DONORS.
ISOLATION AND CHARACTERISATION OF ANTIPLATELET AUTOANTIBODIES FROM A PATIENT IN THE ACUTE PHASE OF POST TRANSFUSION PURPURA.
THE IMPACT OF THE GPIA/IIA-C807T POLYMORPHISM IN PATIENTS WITH STROKE AND IN HIT-PATIENTS
Polymorphism in the platelet glycoprotein Ia and the risk of myocardial infarction and coronary artery disease
POLYMORPHISMS OF PLATELET GP Ibα ASSOCIATED WITH ARTERIAL THROMBOTIC DISEASE.
A MURINE MONOCLONAL ANTIBODY ACTIVATES HUMAN PLATELETS THROUGH INTERACTION WITH HUMAN IMMUNOGLOBULINS
THE EXPRESSION OF UROKINASE RECEPTORS (CD87) ON MEGAKARYOCYTES (MGK) AND PLATELETS
DESCRIPTION OF A NEW QUANTITATIVE AND QUALITATIVE GPIIb-IIIa DEFECT IN A GLANZMANN THROMBASTHENIC PATIENT.
RECOMBINANT NATURAL AUTOANTIBODIES TO GPIIB/IIIA INHIBIT FIBRINOGEN BINDING
ACQUIRED THROMBOASTHENIA DUE TO ANTI GP-Ia/IIa AUTOANTIBODY IN A PATIENT WITH HCV INFECTION.
ACQUIRED GLANZMANN'S DISEASE INDUCED BY PLATELET AUTOANTIBODIES OF THE IGG2 AND IGG4 SUBCLASS.
Influence of platelet factor 4 autoantibodies on the detection of heparin-induced thrombocytopenia type II
FETO-MATERNAL INCOMPATIBILITY IN the NA SYSTEM AND NEONATAL GRANULOCYTOPENIA
DETECTION Of NA1-, NA2- and, SH-SPECIFIC NEUTROPHIL ANTIBODIES USING CHO TRANSFECTANTS
BIOCHEMICAL AND IMMUNOCHEMICAL CHARACTERIZATION OF THE NEUTROPHIL-SPECIFIC ANTIGEN NB1
GENETIC VARIABILITY OF THE NEUTROPHIL FcγRECEPTOR IIIb
THREE SH-POSITIVE DONORS EXPRESS THREE DISTINCT FcγRIIIB GENES: EVIDENCE FOR FcγRIIIB GENE DUPLICATION.
NEONATAL ALLOIMMUNE NEUTROPENIA DUE TO ANTI-SH
NEONATAL ALLOIMMUNE NEUTROPENIA (NAIN) FROM ANTI-FcRIII: RESPONSE TO MATERNAL INTRAVENOUS IMMUNOGLOBULIN (IVIG)
SEROLOGICAL RESULTS AND CLINICAL APPROACH OF 403 NEUTROPHIL AUTOANTIBODIES STUDIES MADE BY FLOW CITOMETRY.
NEUTROPHIL ANTIBODY SPECIFICITY IN AUTOIMMUNE NEUTROPENIA IN CHILDREN
CHRONIC IDIOPATHIC NEUTROPENIA (CIN) IN ADULTS: CLINICAL AND SEROLOGICAL FINDINGS IN 94 PATIENTS.
COMBINED EFFECT OF FC GAMMA RECEPTORS IIA, IIIA, AND IIIB POLYMORPHISMS IN HEPARIN-INDUCED THROMBOCYTOPENIA
FcγRIIA POLYMORPHISM IN A HEALTHY SPANISH POPULATION AND IN PATIENTS WITH MENINGOCOCCAL DISEASE.
FcRn, THE NEONATAL IgG-Fc RECEPTOR, ANALYSIS OF FUNCTIONAL EXPRESSION IN SEVERAL CELL LINES.
DIFFERENTIATION OF IgG-SUBCLASSES OF PLATELET-SPECIFIC ALLOANTIBODIES IN A GLYCOPROTEIN-SPECIFIC PLATELET-ANTIGEN CAPTURE ASSAY
FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) AS A DIRECT METHOD FOR THE EPITOPE-SPECIFIC CHARACTERISATION OF ANTI-PLATELET ANTIBODIES.
HIV-1-SPECIFIC ANTIBODIES AND HIV-1-CROSSREACTIVE ANTIBODIES TO PLATELETS IN HIV-1-INFECTED HEMOPHILIACS.
MECHANISM OF ACTION OF ANTI-D IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA (AITP).
MULTIPLE CARBIMAZOL-DEPENDENT ANTIBODIES IN A PATIENT WITH PANCYTOPENIA
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA IS STILL AN IMMUNE DIAGNOSIS CHALLENGE.
NEONATAL THROMBOCYTOPENIA: IMMUNOLOGICAL PROFILE IN 92 CASES
DIAGNOSTIC AND THERAPEUTIC STRATEGIES IN FETAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO ANTI-Bra (HPA-5b)
IgG TITRE, SUBCLASS, AND LIGHT CHAIN PHENOTYPE OF HPA-5 ANTIBODIES WITH OR WITHOUT NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
RECURRENT POST-TRANSFUSION PURPURA: A CASE REPORT
PROVISION OF SPECIALISED PLATELET TRANSFUSION SUPPORT FOR ALLOIMMUNISED PATIENTS WITHIN A REASONABLE TIMEFRAME.
GENE FREQUENCIES OF THE HPA-1, -2, -3 AND -5 PLATELET ANTIGEN ALLELES IN A BERBER POPULATION.
FETO-MATERNAL ALLOIMMUNIZATION TO PLATELET-SPECIFIC ANTIGENS IN CHILEAN POPULATION
GENOTYPING OF RHD BY MULTIPLEX POLYMERASE CHAIN REACTION ANALYSIS OF SIX RHD SPECIFIC EXONS
DUFFY (Fy) GENOTYPING BY PCR-RFLP: CLINICAL APPLICATIONS
HAPLOTYPES r′ AND r″, A GENETIC SURPRISE
POSSIBLE IMPACT OF THE HPA-COMPATIBILITY ON THE OUTCOME OF THE BONE MARROW TRANSPLANTATION
HPA GENOTYPING BY PCR-SSP: REPORT OF 3 WORKSHOPS
TRANSFUSION SUPPORT WITH FILTERED WASHED RED CELLS TO PREVENT POST-TRANSFUSION PURPURA.
RESPONSE AND NON-RESPONSE TO INTRAVENOUS GAMMA GLOBULIN IN DIFFERENT PREGNANCIES IN THE SAME PATIENT
EFFECT OF THE PASSIVE TRANSFER OF ANTI-HPA-1a ON THE PLATELET COUNTS OF RECIPIENTS
A COMPARISON OF DIFFERENT METHODS FOR THE DETECTION AND SPECIFICATION OF THE ANTIPLATELET ANTIBODIES IN FMAIT
NEONATAL THROMBOCYTOPENIA DUE TO ANTI-HPA-1b
THE FIRST CASE OF SEROLOGICALLY PROVEN HPA-1A NEONATAL ALLOIMMUNE THROMBO-CYTOPENIA (NAITP) IN CROATIA:CASE REPORT
CORRELATION BETWEEN THE SEVERITY OF NEONATAL THROMBOCYTOPENIA AND MATERNAL ANTI-HPA 1a ANTIBODY LEVEL AT TIME OF DELIVERY.
Coincidence of neonatal alloimmune thrombocytopenia and maternal anti-D immunization
ANTI-PLATELET ANTIBODY IDENTIFICATION IN POTENTIAL KIDNEY RECIPIENTS
EVALUATION OF GTI-MODIFIED ANTIGEN CAPTURE ELISA (MACE) FOR THE DETECTION OF IgG ANTIBODIES TO PLATELET AND HLA ANTIGENS.
FAILURE OF AN ENZYME-LINKED IMMUNOSORBENT ASSAY (GTI PakPlus™) TO DETECT SOME CLINICALLY SIGNIFICANT PLATELET ANTIBODIES
WHITE CELL Ab & FEBRILE REACTIONS: DETECTION REGARDLESS OF COMPLEMENT FIXATION
ANTI-HLA CLASS I ANTIBODY DETERMINATION BY EXTENDED CITOTOXICITY AND FLOW-PRA™ SCREENING ASSAYS: COMPARATIVE TESTING RESULTS AND CLINICAL CORRELATION
HLA AND NON-HLA ANTIBODY MONITORING BY CDC AND ELISA IN HIGH RISK PATIENTS BEFORE AND AFTER KIDNEY TRANSPLANTATION AND BLOOD SUPPORT
TAHINI ASSOCIATED THROMBOCYTOPENIA
PROLONGED THROMBOCYTOPENIA IN CHILDREN POST BONE MARROW TRANSPLANTATION.
THROMBOMATCH AND PLATELET- ASSOCIATED IgG (PAIgG): STANDARD DEVIATION HELPS IN DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA (IT)
AUTO-IMMUNE THROMBOCYTOPENIC PURPURA IN PREGNANCY WITH POSITIVE IGM PLATELET-ASSOCIATED IMMUNOGLOBULIN
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A COMPARISON OF THREE DIAGNOSTIC ASSAYS
EVALUATION OF GTI-PAK AUTO A SOLID PHASE ELISA FOR THE DETECTION AUTOANTIBODIES TO PLATELET-SPECIFIC GLYCOPROTEINS (ANTIGENS)
LITTORAL CELL ANGIOMA WITH SEVERE THROMBOCYTOPENIA.
EVALUATION OF LEUCOCYTE-DEPLETED PLATELETS PREPARED IN PAS II FROM BUFFY COATS WITH BAXTER AUTOSTOP FILTER SYSTEM.
PLATELET CONCENTRATES PREPARED IN ADDITIVE SOLUTION
AVAILIBILITY OF BOTH HLA- AND HPA- MATCHED PLATELETS FOR TRANSFUSION.
Platelet transfusions: the management of alloimmunized patients.
PLATELET TRANSFUSION OUTCOME IN NEONATAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
ALTERATIONS IN THE EXPRESSION OF GLYCOPROTEIN (GP) Ibα DURING PROLONGED STORAGE OF PLATELET-RICH PLASMA (PRP)
MAIPA VERSUS LCT TO PREDICT THE SUCCESS OF PLATELET TRANSFUSION
CYTOKINE LEVEL AND IN-VITRO BLEEDING TIME: TOOLS FOR QUALITY CONTROL OF PLATELET CONCENTRATES.
THROMBIN AND PORCINE VON WILLEBRAND FACTOR UTILIZE DIFFERENT TRANSMEMBRANE SIGNALING PATHWAYS TO INDUCE PLATELET ACTIVATION
A NEW METHOD FOR MEASURING PLATELET ACTIVATION STATE.
PRENATAL GENOTYPING OF RH AND KELL ANTIGENS ON AMNIOTIC FLUID DNA
POLYETHYLENE GLYCOL(PeG) IN MICROADSORPTION PROCEDURES TO DETECT RED CELL ALLOANTIBODIES IN THE PRESENCE OF AUTOANTIBODIES
DONATH-LANDSTEINER ANTIBODY DETECTABLE AT 37°C BY THE ANTIGLOBULIN TEST IN A HIV + PATIENT.
ANTI-NA1 ANTIBODIES IN TWO CASES OF TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI).
A CASE OF RECURRENT TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI).
TRANSFUSION-RELATED ACUTE LUNG INJURY IN PATIENT WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA.
PROLONGED, SEVERE NEUTROPENIA IN AN INFANT DUE TO A HIGH-TITER NA2 ALLOANTIBODY.
Neutrophil derived MPO released during exocytosis binds to both lymphocytes and eosinophils
NEUTROPHIL AUTOANTIBODIES: FLOW CITOMETRIC RESULTS ARE RELATED TO CLINICAL DIAGNOSIS.
THE GLAM ASSAY: CHARACTERISATION OF WHITE CELL-REACTIVE Ab ASSOCIATED WITH TRALI